Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps

List view / Grid view

Stuart Jamieson (CPI Biologics)

 

person's hands moving wooden blocks labelled with the letters mRNA and a picture of a syringe - idea of mRNA-based vaccines
person's hands moving wooden blocks labelled with the letters mRNA and a picture of a syringe - idea of mRNA-based vaccines
article

What are the challenges in developing and delivering lipid nanoparticle mRNA-based vaccines?

29 June 2021 | By ,

In response to the COVID-19 pandemic caused by the SARS-CoV-2 virus, the emergence of RNA vaccine technology has enabled rapid development of critical vaccines. Traditional vaccine production methods makerapid development challenging, requiring cell line production of viral proteins and laborious purification development, which requires extensive effort and long timelines. RNA…

Abstract gradient background including dark purple, pink, yellow and white
Abstract gradient background including dark purple, pink, yellow and white
article

Innovations in analytical science: development of rapid, high-throughput glycoanalytics for biopharmaceuticals

16 December 2020 | By , , , , , , , ,

Researchers have developed a novel high-throughput method for the detection of glycans in purified biopharmaceutical samples. In this article, Victoria Smith, Lewis Wharram and Stuart Jamieson discuss their innovative approach and the implications for safety and potency assurance in biopharmaceuticals.